期刊名： Gastroenterology Insights

期刊主页：https://www.mdpi.com/journal/gastroent

肝脏作为人体重要的代谢和解毒器官，一旦发生病变，会对身体造成多方面的危害。本期推文精选了15篇发表在Gastroenterology Insights期刊上关于肝脏疾病方面的论文，希望可以给大家的选题带来一些灵感。

1. Pediatric Obesity-Associated Liver Disease: What Role Does Artificial Intelligence Play in Metabolic Dysfunction-Associated Steatotic Liver Disease?

儿童肥胖相关性肝病：人工智能在代谢功能障碍相关脂肪性肝病（MASLD）中扮演什么角色？

https://www.mdpi.com/2036-7422/17/3/53

Faa, G.; Fraschini, M.; Faa, A.; Piras, M.; Lastretti, M.; Piludu, M.; Dessì, A.; Fanos, V. Pediatric Obesity-Associated Liver Disease: What Role Does Artificial Intelligence Play in Metabolic Dysfunction-Associated Steatotic Liver Disease? Gastroenterol. Insights 2026, 17, 53. https://doi.org/10.3390/gastroent17030053

2. The Role of Primary Care and Noninvasive Testing in the Early Diagnosis of Metabolic-Associated Steatotic Liver Disease (MASLD)

初级医疗与非侵入性检测在代谢相关脂肪性肝病（MASLD）早期诊断中的作用

https://www.mdpi.com/2036-7422/17/1/11

Constantin, A.M.; Nedelescu, M.M.; Tatar, R.; Pop, C.S.; Neculau, A.E.; Aurelian, S.M.; Oancea, C.; Aurelian, J.; Gîdei, S.M.; Stoian, I.M. The Role of Primary Care and Noninvasive Testing in the Early Diagnosis of Metabolic-Associated Steatotic Liver Disease (MASLD). Gastroenterol. Insights 2026, 17, 11. https://doi.org/10.3390/gastroent17010011.

3. Advances in the Pharmacologic Management of MASLD

MASLD 药物治疗管理的进展

https://www.mdpi.com/2036-7422/17/1/17

Madhankumar, S.; Asma, A. Advances in the Pharmacologic Management of MASLD. Gastroenterol. Insights 2026, 17, 17. https://doi.org/10.3390/gastroent17010017.

4. The Evolution of MASLD Management: From Revised Nomenclature to Disease-Modifying Therapies

MASLD管理的演变：从命名修订到疾病修饰治疗

https://www.mdpi.com/2036-7422/17/2/33

Kornatowska, K.; Kopcia?, S.; Wiekiera, M.; Wiekiera, A.; Budzik, P.; Tyniec, M.; Morshed, K. The Evolution of MASLD Management: From Revised Nomenclature to Disease-Modifying Therapies. Gastroenterol. Insights 2026, 17, 33. https://doi.org/10.3390/gastroent17020033.

5. Impact of Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD) and Steatohepatitis (MASH) on Clostridioides difficile Inpatient Outcomes: A Propensity-Matched Study

代谢功能障碍相关脂肪性肝病（MASLD）与脂肪性肝炎（MASH）对艰难梭菌感染住院患者结局的影响：一项倾向性匹配研究

https://www.mdpi.com/2036-7422/17/2/38

Kohli, S.; Philip, A.; Sarpong-Mensah, P.; Akande, Y.; Sheikh, I.-M.I.; George, L.; Agrohi, J.; Mutneja, H. Impact of Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD) and Steatohepatitis (MASH) on Clostridioides difficile Inpatient Outcomes: A Propensity-Matched Study. Gastroenterol. Insights 2026, 17, 38. https://doi.org/10.3390/gastroent17020038.

6. Effects of Aronia melanocarpa-Based Fruit Juices on Metabolic Dysfunction-Associated Fatty Liver Disease in Rats

黑果腺肋花楸（Aronia melanocarpa）果汁对大鼠代谢功能障碍相关脂肪肝病的影响

https://www.mdpi.com/2036-7422/16/3/23

Georgieva, A.; Eftimov, M.; Stefanova, N.; Tzaneva, M.; Denev, P.; Valcheva-Kuzmanova, S. Effects of Aronia melanocarpa-Based Fruit Juices on Metabolic Dysfunction-Associated Fatty Liver Disease in Rats. Gastroenterol. Insights 2025, 16, 23. https://doi.org/10.3390/gastroent16030023.

7. New Definition, New Point of View: Sex and Gender Interpretation of MASLD—Interpretation of Guidelines and Review of the Literature

新定义、新视角：MASLD 的性与性别解读 —— 指南解读与文献综述

https://www.mdpi.com/2036-7422/17/1/7

De Luca, M.; Verdoliva, R.; Lombardi, A.; Giorgio, A. New Definition, New Point of View: Sex and Gender Interpretation of MASLD—Interpretation of Guidelines and Review of the Literature. Gastroenterol. Insights 2026, 17, 7. https://doi.org/10.3390/gastroent17010007.

8. Understanding Why Metabolic-Dysfunction-Associated Steatohepatitis Lags Behind Hepatitis C in Therapeutic Development and Treatment Advances

理解代谢功能障碍相关脂肪性肝炎（MASH）为何在治疗研发与治疗进展上落后于丙型肝炎

https://www.mdpi.com/2036-7422/15/4/66

Ferrari, C.; Ashraf, B.; Saeed, Z.; Tadros, M. Understanding Why Metabolic-Dysfunction-Associated Steatohepatitis Lags Behind Hepatitis C in Therapeutic Development and Treatment Advances. Gastroenterol. Insights 2024, 15, 944-962. https://doi.org/10.3390/gastroent15040066.

9. Non-Alcoholic Fatty Liver Disease, Awareness of a Diagnostic Challenge—A Clinician’s Perspective

非酒精性脂肪性肝病：对诊断挑战的认识 —— 临床医生视角

https://www.mdpi.com/2036-7422/15/4/71

Marginean, C.M.; Pirscoveanu, D.; Cazacu, S.M.; Popescu, M.S.; Marginean, I.C.; Iacob, G.A.; Popescu, M. Non-Alcoholic Fatty Liver Disease, Awareness of a Diagnostic Challenge—A Clinician’s Perspective. Gastroenterol. Insights 2024, 15, 1028-1053. https://doi.org/10.3390/gastroent15040071.

10. Hepatitis C Virus: History and Current Knowledge

丙型肝炎病毒：发展史与现有认知

https://www.mdpi.com/2036-7422/15/3/49

Topi, S.; Gaxhja, E.; Charitos, I.A.; Colella, M.; Santacroce, L. Hepatitis C Virus: History and Current Knowledge. Gastroenterol. Insights 2024, 15, 676-707. https://doi.org/10.3390/gastroent15030049.

11. CT and MR Imaging of Hepatocellular Carcinoma and Liver Cirrhosis

肝细胞癌与肝硬化的 CT 及磁共振成像

https://www.mdpi.com/2036-7422/15/4/68

Okada, M.; Aoki, R.; Nakazawa, Y.; Tago, K.; Numata, K. CT and MR Imaging of Hepatocellular Carcinoma and Liver Cirrhosis. Gastroenterol. Insights 2024, 15, 976-997. https://doi.org/10.3390/gastroent15040068.

12. Smoking and Risk of Fatty Liver Disease: A Meta-Analysis of Cohort Studies

吸烟与脂肪肝患病风险：一项队列研究的荟萃分析

https://www.mdpi.com/2036-7422/16/1/1

Lee, M.; Myung, S.-K.; Lee, S.H.; Chang, Y. Smoking and Risk of Fatty Liver Disease: A Meta-Analysis of Cohort Studies. Gastroenterol. Insights 2025, 16, 1. https://doi.org/10.3390/gastroent16010001

13. Relationship Between Hepatitis B Viral Load and Laboratory Parameters in HBsAg-Positive Patients: Insights from the Sub-Himalayan Region

乙型肝炎表面抗原阳性患者乙肝病毒载量与实验室指标的相关性：次喜马拉雅区域研究启示

https://www.mdpi.com/2036-7422/16/3/29

Negi, A.; Anand, P.; Diksha, D.; Negi, S.; Gupta, S.K.; Kalita, D.; Mathuria, Y.P. Relationship Between Hepatitis B Viral Load and Laboratory Parameters in HBsAg-Positive Patients: Insights from the Sub-Himalayan Region. Gastroenterol. Insights 2025, 16, 29. https://doi.org/10.3390/gastroent16030029.

14. Cytopenias in Compensated Versus Decompensated Liver Function: Is There a Difference?

代偿期与失代偿期肝功能状态下的血细胞减少症：是否存在差异

https://www.mdpi.com/2036-7422/16/4/44

Rodríguez-Negrete, E.V.; Arriaga Pizano, L.A.; Sánchez-Reyes, K.; Anguiano-Robledo, L.; Morales-González, Á.; Rojas-Martínez, R.; Madrigal-Santillán, E.O.; Morales-González, J.A. Cytopenias in Compensated Versus Decompensated Liver Function: Is There a Difference? Gastroenterol. Insights 2025, 16, 44. https://doi.org/10.3390/gastroent16040044.

15. Clinical Value of Ultrasound Fat Fraction in Grading Hepatic Steatosis: Preliminary Cut-Off Values in Obese Patients

超声脂肪分数对肝脂肪变性分级的临床价值：肥胖患者的初步临界值

https://www.mdpi.com/2036-7422/16/4/47

Ibba, F.; Airola, C.; Rozera, T.; Petrucci, L.; Carlino, G.; Varca, S.; Cavallaro, C.; De Matthaeis, N.; Pizzolante, F. Clinical Value of Ultrasound Fat Fraction in Grading Hepatic Steatosis: Preliminary Cut-Off Values in Obese Patients. Gastroenterol. Insights 2025, 16, 47. https://doi.org/10.3390/gastroent16040047.

期刊介绍

主编：Atsushi Sakuraba, RUSH University Medical Center, USA

期刊主题涵盖消化内科学的各个方面，主要发表食管、胃、肠、肝、胆和胰腺等器官的疾病相关论文。

2025 Impact Factor：1.6

2025 CiteScore：2.1

Time to First Decision：19.5 Days

Acceptance to Publication：7.7 Days